Article
FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Brain : a journal of neurology - 1 Sept 2011
Neumann Manuela, Bentmann Eva, Dormann Dorothee, Jawaid Ali, DeJesus-Hernandez Mariely, Ansorge Olaf, Roeber Sigrun, Kretzschmar Hans A, Munoz David G, Kusaka Hirofumi, Yokota Osamu, Ang Lee-Cyn, Bilbao Juan, Rademakers Rosa, Haass Christian, Mackenzie Ian R A
Abstract excerpt
Accumulation of the DNA/RNA binding protein fused in sarcoma as cytoplasmic inclusions in neurons and glial cells is the pathological hallmark of all patients with amyotrophic lateral sclerosis with mutations in FUS as well as in several subtypes of frontotemporal lobar degeneration, which are not associated with FUS mutations. The mechanisms leading to inclusion formation and fused in sarcoma-associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
